The new facility, which will be established as Medicom Kolmi-Hopen Engineering, will help the company to cater to the increasing demand for surgical and respiratory masks across Europe.
Its existing production facility in Saint-Barthelemy-d’Anjou was acquired by the company in 2011 in line with its strategic initiative to diversify mask production globally.
With the launch of a second mask and personal protective equipment (PPE) production facility in Beaucouzé next month, Medicom expects to ramp up its capacity and meet the demand from various European governments.
The company also intends to resume supplying masks to customers in 26 European countries, and in Canada and Hong Kong.
With 11 new lines and an optimised production schedule, mask production at the two sites in France will triple in the next five months.
Kolmi-Hopengeneral manager Gérald Heuliez said: “We are proud of our partnership with the Government of France that worked with us to increase efficiency, increase output and reduce the distribution time of critical equipment for front line workers.
“With that progress, along with the establishment of the new manufacturing plant in July, we will be able to resume supply to other customers and markets.”
Medicom Group global CEO Guillaume Laverdure said: “One of our key strengths is our diversified manufacturing footprint across the globe and our willingness to invest to set up local production such as recently announced in Canada, Singapore and now with a second facility in France.”
The company currently has ten fully controlled manufacturing facilities, including recently opened and announced facilities in Canada and Singapore.